Towards a commercial process for the manufacture of genetically modified T cells for therapy

por Kaiser, A D, Assenmacher, M, Schröder, B, Meyer, M, Orentas, R, Bethke, U, Dropulic, B
Publicado 2015

PB2115: TRIAL IN PROGRESS: A RANDOMIZED PHASE II STUDY OF MB-CART2019.1 COMPARED TO STANDARD OF CARE THERAPY IN PATIENTS WITH RELAPSED/REFRACTORY DLBCL INELIGIBLE FOR AUTOLOGOUS ST...

por Borchmann, P., Vandenberghe, P., Urbano, A., Haioun, C., Lemonnier, F., Griškevicius, L., Maury, S., Holtkamp, S., Friedrichs, B., Zadoyan, G., Hanssens, L., Brillant, C., Bethke, U., Assenmacher, M., Bürger, I., Philippe, B., Overstijns, T., Jäger, U., Kersten, M. J.
Publicado 2022